Controversial vascular access surveillance mandate

Area of Science:

• Nephrology
• Vascular Access Management
• Healthcare Policy

Background:

• The Centers for Medicare and Medicaid Services (CMS) updated requirements for end-stage renal disease (ESRD) dialysis facilities.
• Facilities must now implement ongoing hemodialysis vascular access surveillance programs.

Purpose of the Study:

• To evaluate the evidence-based foundation of the CMS's new vascular access surveillance requirement for ESRD dialysis facilities.
• To propose revisions to the CMS ESRD Interpretive Guidance Update regarding vascular access monitoring.

Main Methods:

• Review of current practices in hemodialysis vascular access surveillance.
• Analysis of existing evidence on the efficacy of surveillance in predicting thrombosis and prolonging graft/fistula life.

Main Results:

• Current surveillance methods (e.g., blood flow, venous pressure) do not accurately predict synthetic graft thrombosis or extend graft longevity.
• Limited evidence suggests monthly surveillance may reduce native arteriovenous fistula thrombosis, but its effect on fistula longevity requires further confirmation.
• The CMS surveillance requirement is not currently evidence-based.

Conclusions:

• The current CMS surveillance requirement for hemodialysis vascular access is not evidence-based.
• Recommend revising the guidance to require only monitoring (e.g., physical examination) pending further research on surveillance efficacy.
• Clinical judgment and individualized patient care should guide vascular access management in ESRD facilities.